Benzophenone CAS NO.119-61-9

Chemical Name:  Benzophenone ; Chinese Supplier
CAS No.: 119-61-9
Molecular Formula: C₁₃H₁₀O
Properties: White to whitish crystal, with light odor. Soluble in alcohol, ether ,and chloroform; insoluble in water.
Specification: (Q/CFH07-2001)

Benzophenone is an ultraviolet radiation absorber and intermediate, such as paints. inks. adhesives. etc. Also the intermediate of organic pigments, medicines, flavors and pesticides. 

White flaky crystal with slight rose fragrance, Boiling point305℃. Flash point138℃.Density 1.1146. Refractive 1.6077, insoluble in water (<0.1g/100mL at 25℃), soluble in ethanol, ether, chloroform
Usage:
1. As a photo initiator, and in UV-curing applications such as inks, imaging products, clear coatings and printed circuit boards. 
2. As a pharmaceutical intermediate, in the preparation of antihistamines and hypnotics 
3. As a chemical intermediate, in the manufacture of pesticides.
4. In perfume, for the flavor and fragrance markets.
Packing: Packed in 25 or 50 kg drums, 25 kg paper bags, or as customer requires.

Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.

In 2008, We passed ISO quality system certificate

In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.

In 2016,  obtain a registered trademark “ BJM ”.

In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.

In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.

In 2020, we registered BJM Pharm Yunmeng Co., Ltd,  and the new production base settled in Geputan chemical park with  a total area of 50000 square meters.

We are specialized in the R&D ,production and sales of Erdosteine ,Pirfenidone, Telmisartan, Letrozole , Sitagliptin phosphate, Dapagliflozin , Tris , IPTG and related intermediates.

We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends.